SeaCrest Wealth Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

SeaCrest Wealth Management’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-73	Closed	-$1K	–	592
2019 Q3	$1K	Hold	73	–	–	﹤0.01%	544
2019 Q2	$2K	Hold	73	–	–	﹤0.01%	516
2019 Q1	$3K	Hold	73	–	–	﹤0.01%	1879
2018 Q4	$3K	Hold	73	–	–	﹤0.01%	1864
2018 Q3	$11K	Hold	73	–	–	﹤0.01%	1626
2018 Q2	$10K	Buy	73 +33	+83%	+$4.99K	﹤0.01%	1630
2018 Q1	$10K	Hold	40	–	–	﹤0.01%	1599
2017 Q4	$11K	Buy	+40	New	+$15.3K	﹤0.01%	1577

Other funds holding VYNT

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SeaCrest Wealth Management's VYNT Position: Q4 2019 in Review

SeaCrest Wealth Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2019, closing a stake of 73 shares — an estimated $1K sold.

SeaCrest Wealth Management first reported a position in VYNT in Q4 2017 and held it in 8 quarters. The position peaked at $11K in Q3 2018. 18 funds tracked by Wall St. Rank hold VYNT as of Q4 2019.

SeaCrest Wealth Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 73 Vyant Bio, Inc. Common Stock shares in Q4 2019, an estimated $1K.
SeaCrest Wealth Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
SeaCrest Wealth Management's Vyant Bio, Inc. Common Stock position peaked at $11K in Q3 2018.
18 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2019.

Based on SeaCrest Wealth Management's 13F filing for Q4 2019, filed 22 Jan 2020.